These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 26494853)

  • 1. Lower Muscle Strength and Increased Visceral Fat Associated With No-reflow and High Gensini Score in STEMI.
    Ayça B; Kafadar D; Avsar M; Avci Iİ; Akın F; Okuyan E; Dinckal MH
    Clin Appl Thromb Hemost; 2017 May; 23(4):367-373. PubMed ID: 26494853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SYNTAX score is a predictor of angiographic no-reflow in patients with ST-elevation myocardial infarction treated with a primary percutaneous coronary intervention.
    Şahin DY; Gür M; Elbasan Z; Kuloğlu O; Şeker T; Kivrak A; Tanboğa İH; Gözübüyük G; Kirim S; Çayli M
    Coron Artery Dis; 2013 Mar; 24(2):148-53. PubMed ID: 23363986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between Gensini score and ST-segment resolution in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Zencirci AE; Zencirci E; Degirmencioglu A; Karakus G; Ugurlucan M; Gunduz S; Ozden K; Erdem A; Karadeniz F; Ekmekci A; Erer H; Sayar N; Eren M
    Kardiol Pol; 2014; 72(6):494-503. PubMed ID: 24408069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma apelin-12 levels may predict in-hospital major adverse cardiac events in ST-elevation myocardial infarction and the relationship between apelin-12 and the neutrophil/lymphocyte ratio in patients undergoing primary coronary intervention.
    Topuz M; Oz F; Akkus O; Sen O; Topuz AN; Bulut A; Ozbicer S; Okar S; Koc M; Gur M
    Perfusion; 2017 Apr; 32(3):206-213. PubMed ID: 27770057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Celık T; Balta S; Demır M; Yıldırım AO; Kaya MG; Ozturk C; Demırkol S; Unlu M; Kılıc S; Aydın İ; Iyısoy A
    Cardiol J; 2016; 23(1):84-92. PubMed ID: 26503078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of initial and residual thrombus burden on the no-reflow phenomenon in patients with ST-segment elevation myocardial infarction.
    Ahn SG; Choi HH; Lee JH; Lee JW; Youn YJ; Yoo SY; Cho BR; Lee SH; Yoon J
    Coron Artery Dis; 2015 May; 26(3):245-53. PubMed ID: 25503419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monocyte heterogeneity in myocardial infarction with and without ST elevation and its association with angiographic findings.
    Arslan U; Kocaoğlu I; Balci MM; Gülkan B; Falay MY; Temizhan A
    Coron Artery Dis; 2013 Aug; 24(5):404-11. PubMed ID: 23612365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gensini Score and Thrombus Burden Add Predictive Value to the SYNTAX Score in Detecting No-Reflow after Myocardial Infarction.
    Matos LCV; Carvalho LS; Modolo R; Santos S; Silva JCQE; Almeida OLR; Sposito AC
    Arq Bras Cardiol; 2021 Mar; 116(3):466-472. PubMed ID: 33656051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of ultrasound attenuation and plaque rupture as detected by intravascular ultrasound on the incidence of no-reflow phenomenon after percutaneous coronary intervention in ST-segment elevation myocardial infarction.
    Endo M; Hibi K; Shimizu T; Komura N; Kusama I; Otsuka F; Mitsuhashi T; Iwahashi N; Okuda J; Tsukahara K; Kosuge M; Ebina T; Umemura S; Kimura K
    JACC Cardiovasc Interv; 2010 May; 3(5):540-9. PubMed ID: 20488411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship of TIMI risk index with SYNTAX and Gensini risk scores in predicting the extent and severity of coronary artery disease in patients with STEMI undergoing primary percutaneous coronary intervention.
    Acet H; Ertaş F; Bilik MZ; Aydın M; Yüksel M; Polat N; Yıldız A; Özyurtlu F; Akıl MA; Çiftçi L; Özbek M; Alan S; Toprak N
    Ther Adv Cardiovasc Dis; 2015 Oct; 9(5):257-66. PubMed ID: 25784498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of lymphocyte-to-monocyte ratio with the no-reflow phenomenon in patients who underwent a primary percutaneous coronary intervention for ST-elevation myocardial infarction.
    Kurtul A; Yarlioglues M; Celik IE; Duran M; Elcik D; Kilic A; Oksuz F; Murat SN
    Coron Artery Dis; 2015 Dec; 26(8):706-12. PubMed ID: 26340546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Importance of Magnesium Values in Patients With STEMI Admitted to the Emergency Department.
    Yuksel M; Isik T; Tanboga IH; Ayhan E; Erimsah ME; Topcu S; Demirelli S; Aksakal E; Sevimli S
    Clin Appl Thromb Hemost; 2017 May; 23(4):329-335. PubMed ID: 27418637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation of serum uric acid levels with coronary flow in patients with ST-segment elevation myocardial infarction undergoing primary coronary intervention].
    Wang JW; Chen YD; Wang CH; Zhu XL
    Zhonghua Yi Xue Za Zhi; 2012 Nov; 92(44):3100-3. PubMed ID: 23328417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of thrombus burden and no-reflow of infarct-related artery in patients with ST-segment elevation myocardial infarction: importance of platelet indices.
    Cakici M; Cetin M; Balli M; Akturk E; Dogan A; Oylumlu M; Abus S; Yildiz E; Sungur A; Celiker M
    Blood Coagul Fibrinolysis; 2014 Oct; 25(7):709-15. PubMed ID: 24806326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association of serum procalcitonin level with the no-reflow phenomenon after a primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction.
    Murat SN; Kurtul A; Celik IE; Duran M; Yarlioglues M; Kilic A; Elcik D
    Coron Artery Dis; 2016 Mar; 27(2):116-21. PubMed ID: 26709984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum B-type natriuretic peptide on admission can predict the 'no-reflow' phenomenon after primary drug-eluting stent implantation for ST-segment elevation myocardial infarction.
    Jeong YH; Kim WJ; Park DW; Choi BR; Lee SW; Kim YH; Lee CW; Hong MK; Kim JJ; Park SW; Park SJ
    Int J Cardiol; 2010 May; 141(2):175-81. PubMed ID: 19144424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraoxonase-1 activity and oxidative stress in patients with anterior ST elevation myocardial infarction undergoing primary percutaneous coronary intervention with and without no-reflow.
    Gür M; Türkoğlu C; Taşkın A; Uçar H; Börekçi A; Seker T; Gözükara MY; Kaypaklı O; Akyol S; Selek S; Sahin DY; Elbasan Z; Caylı M
    Atherosclerosis; 2014 Jun; 234(2):415-20. PubMed ID: 24763406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction.
    Ndrepepa G; Tiroch K; Fusaro M; Keta D; Seyfarth M; Byrne RA; Pache J; Alger P; Mehilli J; Schömig A; Kastrati A
    J Am Coll Cardiol; 2010 May; 55(21):2383-9. PubMed ID: 20488311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive Value of the No-Reflow Phenomenon and Epicardial Adipose Tissue for Clinical Outcomes After Primary Percutaneous Coronary Intervention.
    Zencirci AE; Zencirci E; Değirmencioğlu A; Erdem A; Karakuş G; Özden K; Karadeniz F; Buturak A; Belen E; Tipi F; Eren M
    Hellenic J Cardiol; 2015; 56(4):311-9. PubMed ID: 26233771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of the platelet-to-lymphocyte ratio in predicting angiographic reflow after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction.
    Kurtul A; Yarlioglues M; Murat SN; Ergun G; Duran M; Kasapkara HA; Demircelik MB; Cetin M; Ocek AH
    Am J Cardiol; 2014 Aug; 114(3):342-7. PubMed ID: 24948493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.